Contracts › HHSO100201700017C
HHSO100201700017C: Igf::Ot::Igf
Awarded to Mapp Biopharmaceutical, Inc. by Office of Assistant Secretary for Preparedness and Response.
$116.0Mobligated
$343.6Mpotential value
30 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HHSO100201700017C |
|---|---|
| Awardee | Mapp Biopharmaceutical, Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | AN11 R&D- Medical: Biomedical (Basic Research) |
| Place of performance | CA |
| Offers received | 2 |
| Period of performance | 15 September 2019 to 30 June 2027 |
| Potential end | 30 June 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 07 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record